Skip to main content
. 2015 Dec 29;55:861–873. doi: 10.1007/s40262-015-0360-5

Fig. 1.

Fig. 1

Flow diagram summarising a the data included in the population pharmacokinetic model and b genetic data available for analysis. EFV efavirenz, PK pharmacokinetics, LLQ lower limit of quantification, ITT intention to treat, LC–MS/MS liquid chromatography–tandem mass spectrometry, PCR polymerase chain reaction, WK week